Clinical Trial Update: Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of gemcitabine and oxaliplatin for hepatocellular carcinoma with platelet counts >100,000/µL; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED